Testing effectiveness (Phase 2)Study completedNCT03113825
What this trial is testing
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Who this might be right for
Primary Invasive Malignant Neoplasm of Female BreastCarcinoma BreastBreast Cancer Female+4 more
Avelas Biosciences, Inc. 92